EP1301226A4 - Kits and compositions supporting intracranial perfusions - Google Patents

Kits and compositions supporting intracranial perfusions

Info

Publication number
EP1301226A4
EP1301226A4 EP01954737A EP01954737A EP1301226A4 EP 1301226 A4 EP1301226 A4 EP 1301226A4 EP 01954737 A EP01954737 A EP 01954737A EP 01954737 A EP01954737 A EP 01954737A EP 1301226 A4 EP1301226 A4 EP 1301226A4
Authority
EP
European Patent Office
Prior art keywords
perfusions
intracranial
kits
compositions
supporting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01954737A
Other languages
German (de)
French (fr)
Other versions
EP1301226A2 (en
Inventor
David P Hesson
Glenn David Frazer
Timothy J Pelura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuron Therapeutics Inc
Original Assignee
Neuron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapeutics Inc filed Critical Neuron Therapeutics Inc
Publication of EP1301226A2 publication Critical patent/EP1301226A2/en
Publication of EP1301226A4 publication Critical patent/EP1301226A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/0476Oxygenated solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0693Brain, cerebrum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP01954737A 2000-07-19 2001-07-18 Kits and compositions supporting intracranial perfusions Withdrawn EP1301226A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61941400A 2000-07-19 2000-07-19
US619414 2000-07-19
PCT/US2001/022539 WO2002005870A2 (en) 2000-07-19 2001-07-18 Kits and compositions supporting intracranial perfusions

Publications (2)

Publication Number Publication Date
EP1301226A2 EP1301226A2 (en) 2003-04-16
EP1301226A4 true EP1301226A4 (en) 2004-07-14

Family

ID=24481828

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01954737A Withdrawn EP1301226A4 (en) 2000-07-19 2001-07-18 Kits and compositions supporting intracranial perfusions

Country Status (3)

Country Link
EP (1) EP1301226A4 (en)
AU (1) AU2001276963A1 (en)
WO (1) WO2002005870A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370138A4 (en) * 2001-03-02 2004-08-18 Neuron Therapeutics Inc Gene therapy for neurological tissues
EP2124539A2 (en) 2007-02-17 2009-12-02 President and Fellows of Harvard College Compositions and method for tissue preservation
CN102088968A (en) 2008-02-15 2011-06-08 哈佛学院董事会 Blood substitute solution

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220153A1 (en) * 1985-10-25 1987-04-29 Kabi Pharmacia AB A nutritive emulsion having oxygen-transporting properties, and process for its preparation
WO1988005261A1 (en) * 1987-01-16 1988-07-28 Tops Systems, Inc. Total organ perfusion system
US4981691A (en) * 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
WO2001034225A2 (en) * 1999-11-12 2001-05-17 Neuron Therapeutics, Inc. Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686085A (en) * 1980-04-14 1987-08-11 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US6316403B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981691A (en) * 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
EP0220153A1 (en) * 1985-10-25 1987-04-29 Kabi Pharmacia AB A nutritive emulsion having oxygen-transporting properties, and process for its preparation
WO1988005261A1 (en) * 1987-01-16 1988-07-28 Tops Systems, Inc. Total organ perfusion system
WO2001034225A2 (en) * 1999-11-12 2001-05-17 Neuron Therapeutics, Inc. Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1991, BELL R D ET AL: "A NOVEL TREATMENT FOR ISCHEMIC INTRACRANIAL HYPERTENSION IN CATS", XP002265774, Database accession no. PREV199191087427 *
See also references of WO0205870A3 *
STROKE, vol. 22, no. 1, 1991, pages 80 - 83, ISSN: 0039-2499 *

Also Published As

Publication number Publication date
WO2002005870A2 (en) 2002-01-24
AU2001276963A1 (en) 2002-01-30
WO2002005870A3 (en) 2002-08-15
EP1301226A2 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
EP1341554A4 (en) Colostrum-based composition
AU8404801A (en) Support
GB0003232D0 (en) Novel composition
GB0007736D0 (en) Support member
IL150471A0 (en) Composition
EP1301226A4 (en) Kits and compositions supporting intracranial perfusions
GB0022473D0 (en) Composition
AU8975701A (en) Novel composition and use
GB0007762D0 (en) Composition
PL360674A1 (en) Support
GB2361415B (en) Support structure
GB2366535B (en) Metal cushions
TW410854U (en) Elevated-floor support
GB0024408D0 (en) Support
GB2360449B (en) Adjustable support assembly
GB0011624D0 (en) Dial ads
GB0004272D0 (en) Support
PL111318U1 (en) Supporting member
PL110551U1 (en) Advertising attachment
IL134807A0 (en) Advertisement display
GB0012328D0 (en) Support stands
TW423627U (en) Supporting structure
TW438023U (en) Improved billboard structure
GB0023067D0 (en) Composition
GB0002320D0 (en) Composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030212

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 45/06 B

Ipc: 7A 61K 38/38 B

Ipc: 7A 61K 31/70 B

Ipc: 7A 61K 31/198 B

Ipc: 7A 61K 31/02 B

Ipc: 7A 61M 1/14 A

RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20040601

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040203